Investing Profile

Geert-Jan Mulder

InvestorVC
Managing Partner at Forbion
forbion.comNaarden, Netherlands
Photo of Geert-Jan Mulder, Managing Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
ABN AMRO Bank N.V. Network
35 CONNECTIONS
Forbion Network
15 CONNECTIONS
cb
Forbion Managing Partner
$100K - $5.0M
$1.5M
22
CompanyStageDateRound SizeTotal Raised
Citryll
Series BDec 2024$90M
$110M
Co-investors: Edward Van Wezel (BGV (BioGeneration Ventures)), Isabelle de Cremoux (Seventure Partners), Florian Müllershausen (Novartis Venture Fund)
Mariana Oncology
Series BSep 2023$180M
$250M
Co-investors: Dan Becker (Access Industries), Kevin Bitterman (Atlas Venture), Josh Resnick
Complement Therapeutics
Series AApr 2023$79M
SeedFeb 2022$6M
$85M
Co-investors: Max Klement (BGV (BioGeneration Ventures)), Anne Horgan (Cambridge Innovation Capital), Dmitrij Hristodorov (Forbion)
Prilenia
Series BNov 2021$43M
Series AJun 2020$63M
$110M
AM Pharma
Series UnknownMar 2020$25M
Series FJul 2019$130M
Series CAug 2007$3M
$210M
Co-investors: Laia Crespo (Sanofi Ventures), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Group), Raphael Wisniewski (Andera Partners)
Enterprise Therapeutics
Series BApr 2018$41M
$41M
Co-investors: Alexander Mayweg (Versant Ventures), David Morris
Exosome Diagnostics
Series CJul 2017$30M
Series BJan 2016$16M
Series BSep 2015$18M
Series BMar 2014$27M
Series AMay 2010$20M
$110M
Co-investors: Marco Boorsma (Forbion), Steven Soignet (Arcus Ventures)
NeRRe Therapeutics
Series BJan 2017$29M
$47M
Co-investors: Iain Dukes (OrbiMed), Raj Parekh (Advent Life Sciences)
Medical Adviser HotmailPresent
Clinical Research Manager HotmailPresent
Director ABN AMRO Bank N.V.Present
CMO (interim) HotmailPresent
Managing Partner ForbionPresent